<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03636581</url>
  </required_header>
  <id_info>
    <org_study_id>BHS-1333</org_study_id>
    <nct_id>NCT03636581</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention Program in Overweight Medical Students</brief_title>
  <official_title>A Novel Lifestyle Intervention Program to Improve Body Composition and Chronic Disease Bio Markers in Overweight Medical Students: a Randomized Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York Institute of Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be a randomized cross-over design over the course of 2 academic years. 40
      subjects -20 overweight women and 20 over weight men will be recruited. Each subject will
      have body composition tested, blood lipid profile, and resting metabolic rate done in the
      beginning of the first academic year and at the end of the first academic year. The
      intervention group will receive activity trackers, diet counseling, and fitness counseling
      for one academic year. The second year, all outcome measures (a body scan, blood lipid
      profile, and resting metabolic rate) will be performed again at the start of the academic
      year 2, except the intervention group will now be the control group and the control group
      will now receive the same intervention. All final outcome measures will be performed at the
      end of the second year.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 8, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>4 months</time_frame>
    <description>Body composition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Step Count</measure>
    <time_frame>4 months</time_frame>
    <description>Activity based on step count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>4 months</time_frame>
    <description>Resting metabolic rate changes as per oxygen consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>4 months</time_frame>
    <description>fasting serum mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoproteins</measure>
    <time_frame>4 months</time_frame>
    <description>fasting serum mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Density Lipoproteins</measure>
    <time_frame>4 months</time_frame>
    <description>fasting serum mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>4 months</time_frame>
    <description>fasting serum mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>4 months</time_frame>
    <description>fasting plasma % of total hemoglobin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive a smart watch to track activity and diet. This group will also receive education on nutrition and exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will receive a smart watch to track activity only with no intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle counseling</intervention_name>
    <description>This group will receive online education modules to educate them on exercise prescription, nutrition and behavioral changes.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female NYITCOM students between the ages of 18-35

          -  BMI â‰¥ 25.0

          -  Body fat % &gt;19% for males; &gt;33% for women (will be determined by body composition
             scan)

          -  Own their own smartphone

        Exclusion Criteria:

          -  People who have used weight loss smartphone applications in the past 6 month

          -  People who have used an activity tracker in past 6 months

          -  Anyone who answers yes to one or more questions on the PAR-Q screen

          -  Any contraindication to having a duel x-ray body scan performed based on the American
             College of Radiology's practice guidelines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Donoghue</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Institute of Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Institute of Technology</name>
      <address>
        <city>Old Westbury</city>
        <state>New York</state>
        <zip>11568</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>August 21, 2019</last_update_submitted>
  <last_update_submitted_qc>August 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York Institute of Technology</investigator_affiliation>
    <investigator_full_name>Joanne DiFrancisco-Donoghue</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

